'Warp Speed’ Vaccine Trial Network Aims For Both Harmony And Velocity

Infographic depicts how Operation Warp Speed is harmonizing the study designs of COVID-19 vaccine candidates to make it easier to compare safety and efficacy. 

Warp speed space image for CoVPN Trial network
'Warp Speed' Vaccine Trials Will Share Common Design Elements and Procedures • Source: Shutterstock

Operation Warp Speed is taking baby steps toward US Food and Drug Administration leaders’ long-held goal of pushing for more master protocols in drug development. The late-stage COVID-19 vaccine trials conducted under the umbrella of the government program are being billed as “semi-independent harmonized trials.”

That means that while each company getting support from Warp Speed is operating its own stand-alone Phase III studies and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Vaccines

More from Pink Sheet

Room For Improvement? EU Industry Prepares Feedback For SPC Manufacturing Waiver Review

 
• By 

As the European Commission prepares a formal evaluation of the SPC manufacturing waiver, the generics and biosimilars industry is getting ready to provide detailed feedback on what works – and what doesn’t. At Medicines for Europe’s legal affairs conference, delegates heard the latest updates.

Report Shows Extent Of AI Use In EU Medicines Regulation During 2024

 

The AI observatory, created by the European medicines regulatory network to track the evolving use of artificial intelligence in medicines development and regulation, has issued its first annual report.

Prasad Cites Unproven Theory Defending His COVID-19 Vaccine Decisions

 

In defending his decision to overrule agency staff on three recent COVID-19 vaccine applications, the CBER director questioned the original timing of Pfizer’s COVID-19 vaccine authorization, reviving a long-held, but unproven grievance of President Trump.